Diana Brainard - 19 Sep 2023 Form 4 Insider Report for NEKTAR THERAPEUTICS (NKTR)

Role
Director
Signature
Mark A. Wilson, Attorney-in-Fact
Issuer symbol
NKTR
Transactions as of
19 Sep 2023
Net transactions value
$0
Form type
4
Filing time
20 Sep 2023, 21:07:26 UTC
Previous filing
21 Aug 2023
Next filing
05 Oct 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NKTR Stock Option Award $0 +85,000 $0.000000 85,000 19 Sep 2023 Common Stock 85,000 $0.6800 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option vests in equal monthly installments over the one-year period beginning on September 19, 2023.